Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy
BEVERIDGE, R. A, MILLER, J. A, TAYLOR, W. R, THOMPSON, K. A, SMITH, L. F, UENO, W. M, DOBRZYNSKI, R. F, WARREN, R. D, KATCHER, D, BYRNE, P. J, DUNNING, D. M, WINOKUR, S. H, KALES, A. N, LOCKEY, J. L, CAMBARERI, R. J, BUTLER, T. P, MEISTER, R. J, FIEGERT, J. M, BINDER, R. A, ROBERT, N. J, HEISRATH-EVANS, J, KOCZYK-SCRIPKA, K, PASHKO, S, NORGARD, M. J, BARNES, H. M
Published in Supportive care in cancer (01.07.1997)
Published in Supportive care in cancer (01.07.1997)
Get full text
Journal Article
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppression
Beveridge, R A, Miller, J A, Kales, A N, Binder, R A, Robert, N J, Harvey, J H, Windsor, K, Gore, I, Cantrell, J, Thompson, K A, Taylor, W R, Barnes, H M, Schiff, S A, Shields, J A, Cambareri, R J, Butler, T P, Meister, R J, Feigert, J M, Norgard, M J, Moraes, M A, Helvie, W W, Patton, G A, Mundy, L J, Henry, D, Sheridan, M J
Published in Cancer investigation (1998)
Published in Cancer investigation (1998)
Get more information
Journal Article